x min read

Uptrend Stocks At Street: Horizon Pharma plc (NASDAQ:HZNP), Companhia Siderurgica Nacional (NYSE:SID), PDL BioPharma, Inc. (NASDAQ:PDLI)

Uptrend Stocks At Street: Horizon Pharma plc (NASDAQ:HZNP), Companhia Siderurgica Nacional (NYSE:SID), PDL BioPharma, Inc. (NASDAQ:PDLI)
Written by
Ryan Mitchell
Published on
November 17, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Horizon Pharma plc (NASDAQ:HZNP) Trend Analysis reported that the pricing of a previously released underwritten secondary offering of 11.66M of its ordinary shares held by certain of its existing shareholders, offered at a price to the public of $12.05 per share. Horizon Pharma plc is not issuing new ordinary shares and would not receive any proceeds from the sale of ordinary shares by the selling shareholders in the offering. Horizon Pharma plc (NASDAQ:HZNP) stock hit highest price at $12.34, beginning with a price of $12.05 to the closed at 12.25 by a loss of -1.13% with a day range of $11.87-$12.34. The total market capitalization remained 1.456 Billion, total volume of 6.55 Million shares held in the session was surprisingly higher than its average volume of 1621.22 shares.Companhia Siderurgica Nacional (NYSE:SID) Trend Analysis reported on that its Q3 2014 cement sales reached 589 thousand tonnes, with net revenue of R$120M. During the first nine months of 2014, Iron ore sales volume reached 21.3M tonnes, a 19 percent year-over-year improvement. On the other consideration, Companhia Siderurgica Nacional (NYSE:SID) begun last trade with a price of $2.68 and throughout the trading session climbed at $2.71. The day-trade ended with a decrease of -5.36% to closed at $2.65. The stock is going forward its fifty-two week low with -3.99% and lagging behind from its 52 week high price with -56.46%. SID last month stock price volatility remained 4.53%.PDL BioPharma, Inc. (NASDAQ:PDLI) Trend Analysis reported that the firm has got $30.3M, in addition to previously got revenue interest payments, to conclude PDL's revenue interest agreement with AxoGen, Inc. (AXGN). In October 2012, PDL signed into a structured financing transaction in which the company provided AxoGen with an aggregate of $20.8 million in exchange for royalties on certain AxoGen revenues. Shares of PDL BioPharma, Inc. (NASDAQ:PDLI) opened at $7.86 with 160.64 million outstanding shares and hit to its highest price of $7.94 during the day and finally closed at $7.79 by scoring -1.27%. In the whole session, it traded on volume of 2.87 Million shares, which turned higher than its average volume.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.

Recommended for You